Abraham Ceesay, President at Cerevel Therapeutics Holdings, Inc. (CERE), sold 19,210 shares at $32.50 ($624K) on 2022-08-22, disclosed to the SEC on 2022-08-24.
Open-market sale of $624k CERE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.50 | 9,605 | $312K | 50.0% |
| 2 | $32.50 | 9,605 | $312K | 50.0% |
| Total | $32.50 avg | 19,210 | $624K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |